en.wikipedia.org/wiki/Torosyan_v._Boehringer_Ingelheim_Pharmaceuticals,_Inc.

Torosyan v Boehringer Ingelheim Pharmaceuticals, Inc, 662 A2d 89 (1995) is a US labor law case, concerning the contract of employment in state law for labor ...

www.cadc.uscourts.gov/internet/opinions.nsf/A81BAEEA3D756416852582B100518ADF/$file/16-5356.pdf

Jun 19, 2018 ... With him on the briefs were Michael Sennett and Nicole C. ... Boehringer Ingelheim Pharmaceuticals, Inc. Warren D. .... no privilege at all.

www.law360.com/cases/55c120da7e21ae3645000003

... INC. et al v. HEC PHARM GROUP et al, case number 3:15-cv-05982, from New Jersey Court. ... BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. ...... GREGORY D. MILLER, RIVKIN RADLER LLP TERMINATED: 03/16/2016.

caselaw.findlaw.com/us-dc-circuit/1692869.html

Case opinion for US DC Circuit FEDERAL TRADE COMMISSION v. BOEHRINGER INGELHEIM PHARMACEUTICALS INC. ... marks omitted); accord 8 Charles Alan Wright et al., Federal Practice & Procedure § 2024, at 502 (3d ed. 2010).

www.ftc.gov/system/files/documents/cases/boehringer_dccir_ftc_final_reply_and_response_brief_2017-0821.pdf

Aug 21, 2017 ... attorney was acting as lawyer and that a significant purpose of the .... In re Miller, 438 F.3d 1141 (D.C. Cir. 2006) . ... King Drug Co. of Florence, Inc. v. Cephalon, Inc.,. No. .... Boehringer Ingelheim Pharmaceuticals, Inc., Case ..... would not suddenly abdicate all of her legal skills and training and consider.

www.gpo.gov/fdsys/pkg/USCOURTS-njd-3_15-cv-05982/content-detail.html

Jan 5, 2017 ... 15-5982 - BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al.

archive.hhh.umn.edu/people/mciresi/pdf/MichaelCiresi.pdf

May 26, 2010 ... Robins, Kaplan, Miller & Ciresi. L.L.P. ... Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc. ... Phillip Morris Incorporated, et al. Co-lead ...

www.futuremedicine.com/doi/pdf/10.2217/fon-2017-0666

Jan 29, 2018 ... 8Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, .... exhausted all other treatment options; and were deemed ineligible to ... by regulations, the NPU was stopped in each country once afatinib (GIOTRIF R ; Boehringer Ingelheim Pharma ..... Miller VA, Hirsh V, Cadranel J et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5488108

Apr 10, 2017 ... Funding. Boehringer Ingelheim Pharmaceuticals, Inc. ... All patients provided written informed consent. ..... Miller VA, Hirsh V, Cadranel J, et al.